Department of Maxillofacial Surgery, School of Dentistry, Aichi Gakuin University, Nagoya, Japan.
Department of Oral and Maxillofacial Surgery, Shin-Yurigaoka General Hospital, Kawasaki, Japan.
Int Dent J. 2022 Feb;72(1):123-132. doi: 10.1016/j.identj.2021.02.002. Epub 2021 Mar 18.
The objective of this study was to assess the efficacy of a tobacco cessation intervention conducted by different dental specialists directed at a group of patients with tobacco-related oral diseases or undergoing implant treatment.
The study design was a multicentre, nonrandomized prospective cohort study to examine the effects of smoking cessation. The target patients were current smokers (aged ≥20 years) with an oral potentially malignant disorder or periodontitis and those seeking dental implants. A total of 74 patients were enrolled in the study. All dental specialists who participated in the trial completed an e-learning Japan Smoking Cessation Training Outreach Project (J-STOP) tobacco cessation education programme. Nicotine dependence was evaluated by the Fagerstrom Test for Nicotine Dependence. Cessation status was verified biochemically by measurement of salivary cotinine or exhaled carbon monoxide. Tobacco cessation intervention was implemented for 8 weeks with or without nicotine replacement therapy with follow-up for 12 months.
A total of 61 patients agreed to the tobacco cessation intervention. The mean biochemically confirmed tobacco abstinence rate was 37.7% at month 3, 34.4% at month 6, and 32.8% at month 12. The highest rate of biochemically confirmed tobacco abstinence at month 12 was among patients receiving implant treatment (42.9%) followed by patients with oral potentially malignant disorder (37.1%), and those with periodontitis (21.1%).
This interventional study demonstrates the challenges encountered and the feasibility of tobacco cessation intervention among Japanese patients attending dental specialists who had completed an e-learning course on smoking cessation. Making tobacco cessation an integral part of patient management by dental specialists requires further evaluation.
本研究旨在评估由不同牙科专家针对一组患有与烟草相关的口腔疾病或接受种植治疗的患者进行的戒烟干预的效果。
这是一项多中心、非随机前瞻性队列研究，旨在检验戒烟的效果。目标患者为患有口腔潜在恶性疾病或牙周炎且正在寻求种植牙的当前吸烟者（年龄≥20 岁）。共有 74 名患者入组该研究。所有参与试验的牙科专家均完成了电子学习日本戒烟拓展培训项目（J-STOP）的戒烟教育培训课程。尼古丁依赖程度通过尼古丁依赖程度 Fagerstrom 测试进行评估。通过测量唾液可替宁或呼出的一氧化碳来进行生物化学验证来确定戒烟状态。实施了为期 8 周的戒烟干预，可选择或不选择尼古丁替代疗法，并进行为期 12 个月的随访。
共有 61 名患者同意接受戒烟干预。3 个月时，经生物化学验证的烟草戒断率平均为 37.7%，6 个月时为 34.4%，12 个月时为 32.8%。12 个月时，经生物化学验证的烟草戒断率最高的是接受种植牙治疗的患者（42.9%），其次是患有口腔潜在恶性疾病的患者（37.1%）和患有牙周炎的患者（21.1%）。
这项干预性研究表明，参加牙科专家培训课程的日本患者戒烟干预面临挑战，但具有可行性。使戒烟成为牙科专家患者管理的一个组成部分需要进一步评估。
